Stay updated on JNJ-42165279 in ASD: Efficacy, Safety, Tolerability Clinical Trial

Sign up to get notified when there's something new on the JNJ-42165279 in ASD: Efficacy, Safety, Tolerability Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the JNJ-42165279 in ASD: Efficacy, Safety, Tolerability Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page now presents the NCT03664232 autism study record, including its eligibility criteria, treatment arms, outcome measures, study locations, results-related dates, and study documents, instead of a 403 error.
    Difference
    55%
    Check dated 2026-11-08T23:20:11.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.2 to v3.8.0 while the study page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T23:26:54.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during a transition. The clinical trial record itself continues to show a 403 Forbidden error.
    Difference
    1%
    Check dated 2026-10-25T22:39:42.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The footer revision identifier was updated from v3.7.1 to v3.7.2. The page continues to show a 403 Forbidden message instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-18T23:01:30.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now displays revision v3.7.1 instead of v3.7.0; the study page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T23:13:29.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The study record page displays a 403 Forbidden error instead of the expected content, indicating the page is currently inaccessible and preventing access to trial details.
    Difference
    19%
    Check dated 2026-09-20T22:09:39.000Z thumbnail image

Stay in the know with updates to JNJ-42165279 in ASD: Efficacy, Safety, Tolerability Clinical Trial

Enter your email address, and we'll notify you when there's something new on the JNJ-42165279 in ASD: Efficacy, Safety, Tolerability Clinical Trial page.